Cargando…
POSC65 Cost-Benefit Analysis of Ready-to-Administer Noradrenaline for Hypotensive Emergency on Intensive Care
Autores principales: | Griffin, E, Tweedie, O, Kirk-Bayley, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769601/ http://dx.doi.org/10.1016/j.jval.2021.11.470 |
Ejemplares similares
-
An Economic Analysis of Critical Care Nurse Resourcing Following the Uptake of Ready-to-Administer Noradrenaline for Hypotensive Shock in Adults in England
por: Griffin, Edward, et al.
Publicado: (2021) -
POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico
por: Ponce-de-León, A, et al.
Publicado: (2022) -
POSC254 The Impact of COVID-19 on European HTA Decisions
por: Watson, C, et al.
Publicado: (2022) -
POSC102 High-Flow Nasal Cannula in Patients with COVID-19: Is a Cost-Effective Alternative?
por: Alves Junior, JM, et al.
Publicado: (2022) -
The dynamics of cost and benefit representations by noradrenaline and dopamine neuronal activity, and their relation to goal-directed behavior
por: Richmond, Barry J, et al.
Publicado: (2011)